INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Hospital de Cabueñes
Gijón, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cabueñes (88)
2024
-
Comparative Effectiveness of Teclistamab Versus Real-World Physician’s Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 2, pp. 696-715
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031
-
Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters
Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 281-297
-
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
Nature Communications, Vol. 14, Núm. 1
-
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry
Nefrologia, Vol. 43, Núm. 4, pp. 442-451
-
Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry
Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 4, pp. 608-619
-
Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry
Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293
-
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients
Haematologica, Vol. 108, Núm. 10, pp. 2753-2763
-
Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”
Journal of the American Academy of Dermatology
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
-
Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 253-260
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Derivation and validation of a risk score for admission to the Intensive Care Unit in patients with COVID-19
Revista Clinica Espanola, Vol. 222, Núm. 1, pp. 1-12
-
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775
-
Plaque modification in calcified chronic total occlusions: the PLACCTON study
Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 213-222
-
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 9, pp. e844-e852
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2021
-
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
Scientific Reports, Vol. 11, Núm. 1